[1]
|
陈榕, 成艳美, 郑小飞, 等. 糖尿病与衰老的相关性及机制研究进展[J]. 转化医学杂志, 2023, 12(4): 204-209, 214.
|
[2]
|
汤运梁, 徐积兄. 糖基化终末产物与糖尿病慢性并发症研究进展[J]. 中国老年学杂志, 2017, 37(4): 1012-1015.
|
[3]
|
Twarda-Clapa, A., Olczak, A., Białkowska, A.M. and Koziołkiewicz, M. (2022) Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs. Cells, 11, Article 1312. https://doi.org/10.3390/cells11081312
|
[4]
|
Goldberg, T., Cai, W., Peppa, M., Dardaine, V., Baliga, B.S., Uribarri, J. and Vlassara, H. (2004) Advanced Glycoxidation End Products in Commonly Consumed Foods. Journal of the American Dietetic Association, 104, 1287-1291. https://doi.org/10.1016/j.jada.2004.05.214
|
[5]
|
Shen, C.Y., Lu, C.H., Wu, C.H., Li, K.J., Kuo, Y.M., Hsieh, S.C. and Yu, C.L. (2020) The Development of Maillard Reaction, and Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling Inhibitors as Novel Therapeutic Strategies for Patients with AGE-Related Diseases. Molecules, 25, Article 5591. https://doi.org/10.3390/molecules25235591
|
[6]
|
Ott, C., Jacobs, K., Haucke, E., Santos, A.N., Grune, T. and Simm, A. (2014) Role of Advanced Glycation End Products in Cellular Signaling. Redox Biology, 2, 411-429. https://doi.org/10.1016/j.redox.2013.12.016
|
[7]
|
Tamura, Y., Adachi, H., Osuga, J.I., Ohashi, K., Yahagi, N., Sekiya, M., Okazaki, H., Tomita, S., Iizuka, Y., Shimano, H., Nagai, R., Kimura, S., Tsujimoto, M. and Ishibashi, S. (2003) FEEL-1 and FEEL-2 Are Endocytic Receptors for Advanced Glycation End Products.Journal of Biological Chemistry, 278, 12613-12617. https://doi.org/10.1074/jbc.M210211200
|
[8]
|
Kobori, T., Ganesh, D., Kumano-Kuramochi, M., Torigoe, K. and Machida, S. (2020) Assay for Advanced Glycation End Products Generating Intracellular Oxidative Stress through Binding to Its Receptor. Analytical Biochemistry, 611, Article ID: 114018. https://doi.org/10.1016/j.ab.2020.114018
|
[9]
|
Horiuchi, S., Sakamoto, Y. and Sakai, M. (2003) Scavenger Receptors for Oxidized and Glycated Proteins. Amino Acids, 25, 283-292. https://doi.org/10.1007/s00726-003-0029-5
|
[10]
|
Bucciarelli, L.G., Wendt, T., Rong, L., Lalla, E., Hofmann, M.A., Goova, M.T., Taguchi, A., Yan, S.F., Yan, S.D., Stern, D.M. and Schmidt, A.M. (2002) RAGE Is a Multiligand Receptor of the Immunoglobulin Superfamily: Implications for Homeostasis and Chronic Disease. Cellular and Molecular Life Sciences, 59, 1117-1128. https://doi.org/10.1007/s00018-002-8491-x
|
[11]
|
Park, K.H. and Park, W.J. (2015) Endothelial Dysfunction: Clinical Implications in Cardiovascular Disease and Therapeutic Approaches. Journal of Korean Medical Science, 30, 1213-1225. https://doi.org/10.3346/jkms.2015.30.9.1213
|
[12]
|
Pertynska-Marczewska, M. and Merhi, Z. (2015) Relationship of Advanced Glycation End Products with Cardiovascular Disease in Menopausal Women. Reproductive Sciences, 22, 774-782. https://doi.org/10.1177/1933719114549845
|
[13]
|
朱明敏. 2型糖尿病患者并发大血管病变的危险因素分析[J]. 现代医学与健康研究电子杂志, 2024, 8(1): 122-124.
|
[14]
|
Won, K.B., Chang, H.J., Park, S.H., Hong, S.Y., Jang, Y. and Chung, N. (2012) High Serum Advanced Glycation End-Products Predict Coronary Artery Disease Irrespective of Arterial Stiffness in Diabetic Patients. Korean Circulation Journal, 42, 335-340. https://doi.org/10.4070/kcj.2012.42.5.335
|
[15]
|
Kitano, D., Takayama, T., Nagashima, K., Akabane, M., Okubo, K., Hiro, T. and Hirayama, A. (2016) A Comparative Study of Time-Specific Oxidative Stress after Acute Myocardial Infarction in Patients with and without Diabetes Mellitus. BMC Cardiovascular Disorders, 16, Article No. 102. https://doi.org/10.1186/s12872-016-0259-6
|
[16]
|
Griendling, K.K. and FitzGerald, G.A. (2003) Oxidative Stress and Cardiovascular Injury: Part II: Animal and Human Studies. Circulation, 108, 2034-2040. https://doi.org/10.1161/01.CIR.0000093661.90582.c4
|
[17]
|
Kiuchi, K., Nejima, J., Takano, T., Ohta, M. and Hashimoto, H. (2001) Increased Serum Concentrations of Advanced Glycation End Products: A Marker of Coronary Artery Disease Activity in Type 2 Diabetic Patients. Heart, 85, 87-91. https://doi.org/10.1136/heart.85.1.87
|
[18]
|
Wautier, M.P., Chappey, O., Corda, S., Stern, D.M., Schmidt, A.M. and Wautier, J.L. (2001) Activation of NADPH Oxidase by AGE Links Oxidant Stress to Altered Gene Expression via RAGE. American Journal of Physiology: Endocrinology and Metabolism, 280, E685-E694. https://doi.org/10.1152/ajpendo.2001.280.5.E685
|
[19]
|
Koska, J., Saremi, A., Howell, S., Bahn, G., De Courten, B., Ginsberg, H., Beisswenger, P.J., Reaven, P.D. and VADT Investigators (2018) Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients with Type 2 Diabetes. Diabetes Care, 41, 570-576. https://doi.org/10.2337/dc17-1740
|
[20]
|
Belmokhtar, K., Ortillon, J., Jaisson, S., Massy, Z.A., Boulagnon Rombi, C., Doué, M., Maurice, P., Fritz, G., Gillery, P., Schmidt, A.M., Rieu, P. and Touré, F. (2019) Receptor for Advanced Glycation End Products: A Key Molecule in the Genesis of Chronic Kidney Disease Vascular Calcification and a Potential Modulator of Sodium Phosphate Co-Transporter PIT-1 Expression. Nephrology, Dialysis, Transplantation, 34, 2018-2030. https://doi.org/10.1093/ndt/gfz012
|
[21]
|
Zhuang, A. and Forbes, J.M. (2016) Diabetic Kidney Disease: A Role for Advanced Glycation End-Product Receptor 1 (AGE-R1)? Glycoconjugate Journal, 33, 645-652. https://doi.org/10.1007/s10719-016-9693-z
|
[22]
|
Teissier, T., Quersin, V., Gnemmi, V., Daroux, M., Howsam, M., Delguste, F., Lemoine, C., Fradin, C., Schmidt, A.M., Cauffiez, C., Brousseau, T., Glowacki, F., Tessier, F.J., Boulanger, E. and Frimat, M. (2019) Knockout of Receptor for Advanced Glycation End-Products Attenuates Age-Related Renal Lesions. Aging Cell, 18, e12850. https://doi.org/10.1111/acel.12850
|
[23]
|
Nishad, R., Tahaseen, V., Kavvuri, R., Motrapu, M., Singh, A.K., Peddi, K. and Pasupulati, A.K. (2021) Advanced-Glycation End-Products Induce Podocyte Injury and Contribute to Proteinuria. Frontiers in Medicine, 8, Article 685447. https://doi.org/10.3389/fmed.2021.685447
|